Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABILITY: Coca-Cola to increase imatinib exposure after major gastrectomy
NL-OMON41047Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of imatinib in gastrointestinal stromal tumor (GIST), sponsored by Radboud University Medical Center. Primary endpoint: Effect of Coca-Cola on imatinib exposure. Started Jul 2014; status: active, not recruiting.
02
Drugs
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NL-OMON41047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41047.